Skip to main content

Methylnaltrexone News

Valeant and Progenics Announce FDA Approves Relistor Tablets for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-Cancer Pain

LAVAL, Quebec and TARRYTOWN, N.Y., July 19, 2016 /PRNewswire/ – Valeant Pharmaceuticals International, Inc. (NYSE & TSX: VRX) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced that...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Constipation - Chronic, Constipation

Methylnaltrexone patient information at Drugs.com